OBJECTIVES: Using a novel, specific assay for proBNP(1-108), this study tested the hypotheses that proBNP(1-108) is secreted by both nonfailing and failing human hearts and that proBNP(1-108) secretion is increased in failing hearts. BACKGROUND: The prohormone of B-type natriuretic peptide (proBNP(1-108)) is a 108-amino acid peptide produced primarily by the heart and cleaved into biologically active BNP(1-32) and the biologically inactive NT-proBNP(1-76). It is unknown to what extent increased cardiac proBNP1-108 secretion compared to reduced peripheral processing is responsible for elevated proBNP(1-108) levels in patients with heart failure (HF) compared to subjects without HF. METHODS: The transcardiac gradient of proBNP(1-108) was determined by collecting arterial blood and blood from the coronary sinus (CS). Samples from subjects without overt heart disease (n = 9) were collected during cardiac catheterization after coronary artery disease had been excluded. Samples from HF patients (n = 21) were collected during implantation of a biventricular pacemaker. ProBNP(1-108) was measured with a new assay. Values are medians (25th/75th percentiles). RESULTS: The gradient of proBNP(1-108) across the nonfailing hearts was 8 (2/20) ng/l (aorta: 15 [1/25] ng/l; CS: 24 [8/41] ng/l; p = 0.018). The transcardiac gradient of proBNP(1-108) in the failing hearts was 326 (96/482) ng/l (arterial: 381 [201/586] ng/l; CS: 709 [408/1,087] ng/l; p<0.001). The transcardiac gradient was greater in failing than nonfailing hearts (p = 0.001). CONCLUSIONS: ProBNP(1-108) is secreted by nonfailing and failing human hearts, but more so in the latter. It remains to be established where peripheral processing of proBNP(1-108) occurs and how this is affected by disease.
OBJECTIVES: Using a novel, specific assay for proBNP(1-108), this study tested the hypotheses that proBNP(1-108) is secreted by both nonfailing and failing human hearts and that proBNP(1-108) secretion is increased in failing hearts. BACKGROUND: The prohormone of B-type natriuretic peptide (proBNP(1-108)) is a 108-amino acid peptide produced primarily by the heart and cleaved into biologically active BNP(1-32) and the biologically inactive NT-proBNP(1-76). It is unknown to what extent increased cardiac proBNP1-108 secretion compared to reduced peripheral processing is responsible for elevated proBNP(1-108) levels in patients with heart failure (HF) compared to subjects without HF. METHODS: The transcardiac gradient of proBNP(1-108) was determined by collecting arterial blood and blood from the coronary sinus (CS). Samples from subjects without overt heart disease (n = 9) were collected during cardiac catheterization after coronary artery disease had been excluded. Samples from HF patients (n = 21) were collected during implantation of a biventricular pacemaker. ProBNP(1-108) was measured with a new assay. Values are medians (25th/75th percentiles). RESULTS: The gradient of proBNP(1-108) across the nonfailing hearts was 8 (2/20) ng/l (aorta: 15 [1/25] ng/l; CS: 24 [8/41] ng/l; p = 0.018). The transcardiac gradient of proBNP(1-108) in the failing hearts was 326 (96/482) ng/l (arterial: 381 [201/586] ng/l; CS: 709 [408/1,087] ng/l; p<0.001). The transcardiac gradient was greater in failing than nonfailing hearts (p = 0.001). CONCLUSIONS: ProBNP(1-108) is secreted by nonfailing and failing human hearts, but more so in the latter. It remains to be established where peripheral processing of proBNP(1-108) occurs and how this is affected by disease.
Authors: Ute Schellenberger; Jessica O'Rear; Andrew Guzzetta; Rodney A Jue; Andrew A Protter; N Stephen Pollitt Journal: Arch Biochem Biophys Date: 2006-04-19 Impact factor: 4.013
Authors: Carolyn S P Lam; John C Burnett; Lisa Costello-Boerrigter; Richard J Rodeheffer; Margaret M Redfield Journal: J Am Coll Cardiol Date: 2007-03-06 Impact factor: 24.094
Authors: Lisa C Costello-Boerrigter; Guido Boerrigter; Margaret M Redfield; Richard J Rodeheffer; Lynn H Urban; Douglas W Mahoney; Steven J Jacobsen; Denise M Heublein; John C Burnett Journal: J Am Coll Cardiol Date: 2006-01-04 Impact factor: 24.094
Authors: Adam M Hawkridge; Denise M Heublein; H Robert Bergen; Alessandro Cataliotti; John C Burnett; David C Muddiman Journal: Proc Natl Acad Sci U S A Date: 2005-11-17 Impact factor: 11.205
Authors: Martin Magnusson; Amra Jujic; Bo Hedblad; Gunnar Engström; Margaretha Persson; Joachim Struck; Nils G Morgenthaler; Peter Nilsson; Christopher Newton-Cheh; Thomas J Wang; Olle Melander Journal: J Clin Endocrinol Metab Date: 2011-11-23 Impact factor: 5.958
Authors: Y Kambayashi; K Nakao; M Mukoyama; Y Saito; Y Ogawa; S Shiono; K Inouye; N Yoshida; H Imura Journal: FEBS Lett Date: 1990-01-01 Impact factor: 4.124
Authors: Paul M McKie; Richard J Rodeheffer; Alessandro Cataliotti; Fernando L Martin; Lynn H Urban; Douglas W Mahoney; Steven J Jacobsen; Margaret M Redfield; John C Burnett Journal: Hypertension Date: 2006-04-03 Impact factor: 10.190
Authors: Christian Mueller; André Scholer; Kirsten Laule-Kilian; Benedict Martina; Christian Schindler; Peter Buser; Matthias Pfisterer; André P Perruchoud Journal: N Engl J Med Date: 2004-02-12 Impact factor: 91.245
Authors: Faquan Liang; Jessica O'Rear; Ute Schellenberger; Lungkuo Tai; Michael Lasecki; George F Schreiner; Fred S Apple; Alan S Maisel; N Stephen Pollitt; Andrew A Protter Journal: J Am Coll Cardiol Date: 2007-02-26 Impact factor: 24.094
Authors: Brenda K Huntley; Sharon M Sandberg; Denise M Heublein; S Jeson Sangaralingham; John C Burnett; Tomoko Ichiki Journal: Circ Heart Fail Date: 2014-10-22 Impact factor: 8.790
Authors: Lasse H Hansen; Thomas Daugbjerg Madsen; Christoffer K Goth; Henrik Clausen; Yang Chen; Nina Dzhoyashvili; Seethalakshmi R Iyer; S Jeson Sangaralingham; John C Burnett; Jens F Rehfeld; Sergey Y Vakhrushev; Katrine T Schjoldager; Jens P Goetze Journal: J Biol Chem Date: 2019-06-11 Impact factor: 5.157
Authors: Ieva Bagdonaite; Emil M H Pallesen; Mathias I Nielsen; Eric P Bennett; Hans H Wandall Journal: Adv Exp Med Biol Date: 2021 Impact factor: 3.650
Authors: Jens P Goetze; Benoit G Bruneau; Hugo R Ramos; Tsuneo Ogawa; Mercedes Kuroski de Bold; Adolfo J de Bold Journal: Nat Rev Cardiol Date: 2020-05-22 Impact factor: 32.419